| |
| |
|
| Insider
Information: |
Bay City Capital Fund V Co-Investment Fund Lp |
| Relationship: |
10% Owner |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
4,629,507 |
|
|
Indirect Shares
|
6,327,195 |
|
|
| Direct
Value |
$3,721,805 |
|
|
|
Indirect Value
|
$4,556,415 |
|
|
| Total
Shares |
10,956,702 |
|
|
| Total
Value |
$8,278,220 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Viracta Therapeutics Ord Shs |
VIRX |
10% Owner |
2014-08-28 |
4,593,687 |
2015-07-24 |
5,623,815 |
Premium* |
|
|
Hyperion Therapeutics Inc |
HPTX |
10% Owner |
2013-10-18 |
35,820 |
2012-07-31 |
0 |
Premium* |
|
|
Enliven Therapeutics Ord Shs |
ELVN |
10% Owner |
2020-03-16 |
0 |
2020-03-16 |
703,380 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ELVN |
Enliven Therapeutics Ord ... |
10% Owner |
– – • |
2020-03-16 |
4 |
A |
$0.00 |
$0 |
I/I |
703,380 |
703,380 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
10% Owner |
– – • |
2015-07-24 |
4 |
S |
$3.46 |
$2,199,529 |
I/I |
(635,702) |
5,623,815 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
10% Owner |
– – • |
2015-07-24 |
4 |
OE |
$1.32 |
$2,198,896 |
I/I |
1,665,830 |
5,627,777 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
10% Owner |
– – • |
2014-08-28 |
4 |
S |
$7.89 |
$1,577,020 |
D/D |
(200,000) |
4,593,687 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
10% Owner |
– – • |
2014-08-27 |
4 |
S |
$8.16 |
$822,014 |
D/D |
(100,700) |
4,793,687 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
10% Owner |
– – • |
2014-08-12 |
4 |
S |
$6.77 |
$251,230 |
D/D |
(37,100) |
4,894,387 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
10% Owner |
– – • |
2014-08-11 |
4 |
S |
$6.90 |
$218,103 |
D/D |
(31,600) |
4,931,487 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
10% Owner |
– – • |
2014-08-08 |
4 |
S |
$6.62 |
$4,468,568 |
D/D |
(675,000) |
4,963,087 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
10% Owner |
– – • |
2013-10-18 |
4 |
OE |
$26.00 |
$5,200,000 |
D/D |
200,000 |
35,820 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
10% Owner |
– – • |
2013-07-19 |
4 |
OE |
$26.69 |
$138,788 |
D/D |
5,200 |
39,560 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
10% Owner |
– – • |
2013-07-18 |
4 |
OE |
$26.00 |
$96,278 |
D/D |
3,703 |
39,657 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
10% Owner |
– – • |
2013-07-17 |
4 |
OE |
$26.00 |
$2,262,000 |
D/D |
87,000 |
39,726 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
10% Owner |
– – • |
2013-07-10 |
4 |
OE |
$22.35 |
$1,158,302 |
D/D |
51,830 |
41,403 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
10% Owner |
– – • |
2013-07-10 |
4/A |
OE |
$22.35 |
$1,158,302 |
D/D |
51,830 |
41,353 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
10% Owner |
– – • |
2013-07-09 |
4/A |
OE |
$22.50 |
$24,754 |
D/D |
1,100 |
42,322 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
10% Owner |
– – • |
2013-07-09 |
4 |
OE |
$22.50 |
$24,754 |
D/D |
1,100 |
42,372 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
10% Owner |
– – • |
2013-07-08 |
4 |
OE |
$22.50 |
$200,250 |
D/D |
8,900 |
42,393 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
10% Owner |
– – • |
2013-07-08 |
4/A |
OE |
$22.50 |
$200,250 |
D/D |
8,900 |
42,343 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
10% Owner |
– – • |
2013-07-05 |
4/A |
OE |
$22.50 |
$63,000 |
D/D |
2,800 |
42,509 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
10% Owner |
– – • |
2013-07-05 |
4 |
OE |
$22.50 |
$2,250 |
D/D |
100 |
42,559 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
10% Owner |
– – • |
2013-07-03 |
4 |
OE |
$22.50 |
$299,315 |
D/D |
13,300 |
42,561 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
10% Owner |
– – • |
2013-06-28 |
4 |
OE |
$22.51 |
$357,059 |
D/D |
15,860 |
42,810 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
10% Owner |
– – • |
2013-06-27 |
4 |
OE |
$22.53 |
$225,333 |
D/D |
10,000 |
43,107 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
10% Owner |
– – • |
2013-05-30 |
4 |
S |
$21.00 |
$112,686 |
D/D |
(5,366) |
43,083 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
10% Owner |
– – • |
2013-05-28 |
4 |
S |
$21.08 |
$252,960 |
D/D |
(12,000) |
43,183 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
